| P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation J Paredes, A Albergaria, JT Oliveira, C Jerónimo, F Milanezi, FC Schmitt Clinical cancer research 11 (16), 5869-5877, 2005 | 567 | 2005 |
| Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer H Usadel, J Brabender, KD Danenberg, C Jerónimo, S Harden, J Engles, ... Cancer research 62 (2), 371-375, 2002 | 425 | 2002 |
| Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. M Carvalho, PJ Ferreira, VS Mendes, R Silva, JA Pereira, C Jerónimo, ... Food and chemical toxicology 48 (1), 441-447, 2010 | 424 | 2010 |
| Molecular detection of prostate cancer in urine by GSTP1 hypermethylation P Cairns, M Esteller, JG Herman, M Schoenberg, C Jeronimo, ... Clinical cancer research 7 (9), 2727-2730, 2001 | 422 | 2001 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 394 | 2024 |
| Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma C Jerónimo, H Usadel, R Henrique, J Oliveira, C Lopes, WG Nelson, ... Journal of the National Cancer Institute 93 (22), 1747-1752, 2001 | 392 | 2001 |
| A quantitative promoter methylation profile of prostate cancer C Jerónimo, R Henrique, MO Hoque, E Mambo, FR Ribeiro, G Varzim, ... Clinical Cancer Research 10 (24), 8472-8478, 2004 | 327 | 2004 |
| The timeline of epigenetic drug discovery: from reality to dreams A Ganesan, PB Arimondo, MG Rots, C Jeronimo, M Berdasco Clinical epigenetics 11, 1-17, 2019 | 309 | 2019 |
| TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas, paired HGPIN lesions N Cerveira, FR Ribeiro, A Peixoto, V Costa, R Henrique, C Jerönimo, ... Neoplasia 8 (10), 826-832, 2006 | 307 | 2006 |
| Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors M Sanchez-Cespedes, P Parrella, S Nomoto, D Cohen, Y Xiao, M Esteller, ... Cancer research 61 (19), 7015-7019, 2001 | 303 | 2001 |
| Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer MO Hoque, Q Feng, P Toure, A Dem, CW Critchlow, SE Hawes, T Wood, ... Journal of Clinical Oncology 24 (26), 4262-4269, 2006 | 299 | 2006 |
| Mitochondrial mutations in early stage prostate cancer and bodily fluids C Jeronimo, S Nomoto, OL Caballero, H Usadel, R Henrique, G Varzim, ... Oncogene 20 (37), 5195-5198, 2001 | 295 | 2001 |
| Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer MO Hoque, S Begum, O Topaloglu, C Jeronimo, E Mambo, WH Westra, ... Cancer research 64 (15), 5511-5517, 2004 | 292 | 2004 |
| Epigenetics in prostate cancer: biologic and clinical relevance C Jerónimo, PJ Bastian, A Bjartell, GM Carbone, JWF Catto, SJ Clark, ... European urology 60 (4), 753-766, 2011 | 258 | 2011 |
| Diagnostic and prognostic epigenetic biomarkers in cancer P Costa-Pinheiro, D Montezuma, R Henrique, C Jerónimo Epigenomics 7 (6), 1003-1015, 2015 | 228 | 2015 |
| Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis MF Spafford, WM Koch, AL Reed, JA Califano, LH Xu, CF Eisenberger, ... Clinical Cancer Research 7 (3), 607-612, 2001 | 222 | 2001 |
| Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma AL Carvalho, C Jeronimo, MM Kim, R Henrique, Z Zhang, MO Hoque, ... Clinical Cancer Research 14 (1), 97-107, 2008 | 214 | 2008 |
| Genome-wide promoter analysis uncovers portions of the cancer methylome MO Hoque, MS Kim, KL Ostrow, J Liu, GBA Wisman, HL Park, ML Poeta, ... Cancer research 68 (8), 2661-2670, 2008 | 208 | 2008 |
| Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples VL Costa, R Henrique, SA Danielsen, S Duarte-Pereira, M Eknaes, ... Clinical Cancer Research 16 (23), 5842-5851, 2010 | 206 | 2010 |
| Molecular detection of prostate cancer: a role for GSTP1 hypermethylation R Henrique, C Jerónimo European urology 46 (5), 660-669, 2004 | 181 | 2004 |
Rui HenriqueProfessor of Pathology, University of PortoVerified email at icbas.up.pt